Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets open in 2 hours 26 minutes
NZX 50
11,671.19
-96.21
(-0.82%)
NZD/USD
0.6132
-0.0013
(-0.21%)
ALL ORDS
8,010.50
-5.30
(-0.07%)
OIL
81.47
-0.10
(-0.12%)
GOLD
2,342.70
-4.20
(-0.18%)
Hyloris Pharmaceuticals SA (0AB6.L)
LSE - LSE Delayed price. Currency in EUR
Add to watchlist
11.70
-1.08
(-8.47%)
At close: 05:10PM BST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,814
2,951
3,096
175
91
Cost of revenue
93
94
107
145
66
Gross profit
2,721
2,857
2,989
30
25
Operating expenses
Research development
14,749
10,151
5,056
3,413
4,577
Selling general and administrative
5,653
3,517
2,900
2,194
808
Total operating expenses
18,810
13,365
13,337
5,586
5,299
Operating income or loss
-16,089
-10,508
-10,348
-5,556
-5,274
Interest expense
393
219
556
992
411
Income before tax
-15,762
-10,766
-11,282
-7,145
-5,782
Income tax expense
0
4
297
1
-14
Income from continuing operations
-15,762
-10,770
-11,579
-7,146
-5,768
Net income
-15,762
-10,770
-11,579
-7,145
-5,373
Net income available to common shareholders
-15,762
-10,770
-11,579
-7,145
-5,373
Basic EPS
-0.46
-0.40
-0.45
-0.33
-0.23
Diluted EPS
-0.46
-0.40
-0.45
-0.33
-0.23
Basic average shares
-
27,199
25,833
21,819
23,552
Diluted average shares
-
27,199
25,833
21,819
23,552
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.